TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Alpha-Hederin, Paclitaxel
Phytochemical Name Alpha-Hederin (PubChem CID: 73296 )
Anticancer drug Name Paclitaxel (PubChem CID: 36314 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 255
Pair Name Alpha-Hederin, Paclitaxel
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Induction-->Autophagy
Gene Regulation Up-regulation Cleavage CASP3 hsa836
Up-regulation Cleavage PARP1 hsa142
Up-regulation Expression ROS1 hsa6098
Up-regulation Expression SQSTM1 hsa8878
In Vitro Model NCI-H1299 Lung large cell carcinoma Homo sapiens (Human) CVCL_0060
NCI-H1650 Minimally invasive lung adenocarcinoma Homo sapiens (Human) CVCL_1483
Result Our findings suggest that α-Hed can increase the killing effect of Tax on NSCLC cells by promoting ROS accumulation, and that combining α-Hed with classical Tax represents a novel strategy for treating NSCLC.
03. Reference
No. Title Href
1 The Novel Autophagy Inhibitor Alpha-Hederin Promoted Paclitaxel Cytotoxicity by Increasing Reactive Oxygen Species Accumulation in Non-Small Cell Lung Cancer Cells. Int J Mol Sci. 2018 Oct 18;19(10):3221. doi: 10.3390/ijms19103221. Click
It has been 46789 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP